Tickerplace logo

Tickerplace

Avalo Therapeutics, Inc. logo

AVTXAvalo Therapeutics, Inc.

AVTX Stock Price, Valuation & Chart | Avalo Therapeutics, Inc.

Compare
$19.340+0.39 (+2.06%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyAVTX intrinsic valueAVTX calculated fair value vs price
OverviewFinancialsDividendsRatios

AVTX Historical price chart

AVTX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization1.02B
PE Ratio-4.08
EPS-4.74
Trading Volume987.86K
Today's High/Low19.86/19.0
Dividend Yield0.00
52 Week High/Low24.27/8.73
Shares Outstanding52.57M
AVTX Financial Statement
AVTX Analyst ratings
AVTX Analysis & performance metrics

AVTX Company profile

Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in…

AVTX Management team

Management
Christopher Ryan Sullivan CPACFO
Chief Financial Officer & Head of Investor relations
Mittie Doyle FACR, M.D.
Chief Medical Officer
Solomon H. Snyder M.D.
Founder and Chairman of Scientific Advisory Board
Garry A. Neil M.D.CEO
President, Chief Executive Officer & Director
Barbara S. Slusher Ph.D.
Founder and Member of Scientific Advisory Board
Paul C. Varki J.D., M.P.H
Chief Legal Officer
Lisa Hegg Ph.D.
Senior Vice President of Program Management, Business Development & Corporate Infrastructure
Colleen Matkowski
Senior Vice President of Global Regulatory Affairs & Quality Assurance
Total 8 executives

AVTX Frequently asked questions

What is Avalo Therapeutics, Inc. (AVTX) Stock Price?

Current stock price of Avalo Therapeutics, Inc. (AVTX) stock is $19.340. The stock price is +2.06% higher in the session. The intraday range can be seen from this page. Volume of Avalo Therapeutics, Inc. (AVTX) stock is 987.86K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Avalo Therapeutics, Inc. (AVTX) stock price going up or down today?

The stock price of Avalo Therapeutics, Inc. (AVTX) can change with earnings, company news, and overall market sentiment. Avalo Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Avalo Therapeutics, Inc. stock expensive at its current price?

Whether Avalo Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for AVTX on this page is -4.08. EPS on this page is -4.74. Compare those figures with peers and growth expectations before deciding if the current Avalo Therapeutics, Inc. price is justified.

How has the stock price of Avalo Therapeutics, Inc. (AVTX) performed historically?

Historical performance for Avalo Therapeutics, Inc. (AVTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how AVTX reacted to past earnings and market events.

Should I buy Avalo Therapeutics, Inc. (AVTX) stock, at this price?

Buying Avalo Therapeutics, Inc. (AVTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.